You have searched for "clinical trial"
Showing 1-10 of 1203
Our columnist attempts to answer this question on many people's minds with the currently-available data.
Facilities across the continent are producing doses under license from overseas pharmaceutical firmsSo far output has involved ‘filling and finishing’ and been well short of local demand
In a medical first, researchers harnessed the brain waves of a paralysed man unable to speak – and turned what he intended to say into sentences on a computer screen.
PETALING JAYA: The necessity for a booster jab to counter Covid-19 remains a huge debate even within the global community.
PETALING JAYA: The Health Ministry has denied a viral message claiming that they are allowing off-label usage of the anti-parasitic drug Ivermectin to treat Covid-19.
People with full Covid-19 vaccination don't need booster for now, say US agencies - contrary to Pfizer’s stance
WASHINGTON (The Straits Times/ANN): People in America who are fully vaccinated against the coronavirus do not need booster shots at this time, US federal agencies said on Thursday (July 8), signalling a more conservative approach that diverged from vaccine developers Pfizer and BioNTech’s plans to develop and roll out vaccine boosters.
NEW YORK: Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker's top scientist said on Thursday, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant.
KUALA LUMPUR (Bernama): Malaysian firm Yong Tai Bhd, which has partnered with China-based Shenzhen Kangtai Biological Products Co. Ltd. (SZKT) to supply Chinese-produced Covid-19 vaccine in Malaysia, is targeting to offer its vaccines to the private sector by September or October.